Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Degeneration (AMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07520318
What this trial is testing

This is a 96-week, Multicenter Study in Patients With Neovascular AMD That Evaluates OCUL101 for Efficacy, Safety, Durability, and Pharmacokinetics, Comparing it With Another Treatment. The Study Will be Conducted in Two Parts, Part A and Part B.

Who this might be right for
Adults With Neovascular Age-related Macular Degeneration
Shenzhen Oculgen Biomedical Technology Co., Ltd. 255
Not applicableWithdrawnNCT00820742
What this trial is testing

Efficacy, Safety, Tolerability of Pegaptanib Sodium (Macugen) in Filipino Patients With Neovascular Age Related Macular Degeneration.

Who this might be right for
Neovascular Age-related Macular Degeneration
Pfizer
Early research (Phase 1)UnknownNCT02613559
What this trial is testing

Evaluation the Pharmacokinetics, Safety, Tolerability of TK001 in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Jiangsu T-Mab Biopharma Co.,Ltd 27
Not applicableUnknownNCT04469140
What this trial is testing

Non Exudative AMD Imaged With SS-OCT- Extension

Who this might be right for
Dry Macular Degeneration
Boston Image Reading Center 450
Large-scale testing (Phase 3)Active Not RecruitingNCT05972473
What this trial is testing

Evaluate the Efficacy and Safety of IBI302 in Subjects With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Innovent Biologics (Suzhou) Co. Ltd. 600
Not applicableStudy completedNCT01712035
What this trial is testing

Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Oregon Health and Science University 44
Testing effectiveness (Phase 2)Study completedNCT02903576
What this trial is testing

Stem Cell Therapy for Outer Retinal Degenerations

Who this might be right for
Age Related Macular DegenerationStargardt's DiseaseExudative Age-related Macular Degeneration
Federal University of São Paulo 15
Early research (Phase 1)Study completedNCT04537884
What this trial is testing

Safety and Tolerability Study of UBX1325 in Patients With Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration

Who this might be right for
Diabetic Macular EdemaNeovascular Age-related Macular Degeneration
Unity Biotechnology, Inc. 19
Not applicableUnknownNCT05222633
What this trial is testing

Anti-VEGF in Real-world

Who this might be right for
Neovascular Age-related Macular EdemaDiabetic Macular EdemaChoroidal Neovascular Membrane+3 more
Wenbin Wei 1,000
Large-scale testing (Phase 3)Study completedNCT00469352
What this trial is testing

Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD

Who this might be right for
Macular Degeneration
Oregon Health and Science University 150
Not applicableActive Not RecruitingNCT06929143
What this trial is testing

Learn More About the Use of Aflibercept in Routine Medical Practice in Japanese Participants With Neovascular Age-related Macular Degeneration and Diabetic Macular Edema

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Diabetic Macular Edema (DME)
Bayer 3,000
Large-scale testing (Phase 3)Looking for participantsNCT07482176
What this trial is testing

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Wet AMD
Adverum Biotechnologies, Inc. 534
Early research (Phase 1)Study completedNCT01013376
What this trial is testing

A Pilot Study of the Safety of MC-1101 in Both Normal Volunteers and Patients With Early Dry AMD

Who this might be right for
Age-Related Macular Degeneration
MacuCLEAR, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT02181504
What this trial is testing

Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Allergan 25
Post-approval studies (Phase 4)Study completedNCT06683950
What this trial is testing

Switching to Aflibercept 8mg in Patients Showing Limited Response to Previous Treatment

Who this might be right for
Age-related Macular Degeneration (ARMD)
Kim's Eye Hospital 35
Early research (Phase 1)Active Not RecruitingNCT05904691
What this trial is testing

Safety and Tolerability of OCU-10-C-110 for Injection in Subjects With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Ocugenix Corporation 24
Not applicableStudy completedNCT02707575
What this trial is testing

Cytokeratin 8 Level in Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Gangnam Severance Hospital 58
Large-scale testing (Phase 3)Looking for participantsNCT07496567
What this trial is testing

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

Who this might be right for
Macular DegenerationAge-Related Macular DegenerationChoroidal Neovascularization+1 more
EyeBiotech Ltd. 960
Early research (Phase 1)Ended earlyNCT00403442
What this trial is testing

Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD

Who this might be right for
Macular Degeneration
Vitreous -Retina- Macula Consultants of New York 10
Not applicableStudy completedNCT07235527
What this trial is testing

Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degeneration

Who this might be right for
Age Related Macular DegenerationExudative Age-Related Macular DegenerationAnti Vascular Endothelial Growth Factor
Saglik Bilimleri Universitesi 54
Next Page